Ligand validation:7PZ3

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7PZ3_EPE_A_304	11%	50%	0.25	0.768	0.74	1.19	1	2	0	0	100%	0.6
7PZ5_EPE_A_304	32%	51%	0.201	0.875	0.67	1.2	1	2	0	0	100%	0.6
7PZ6_EPE_A_304	31%	55%	0.195	0.864	0.75	0.99	1	-	0	0	100%	0.6
7PZ8_EPE_A_304	20%	50%	0.211	0.816	0.75	1.16	1	-	0	0	100%	0.6
7PZ4_EPE_A_304	13%	61%	0.255	0.798	0.58	0.89	1	1	0	0	100%	0.6
1XX1_EPE_C_2003	100%	37%	0.024	0.996	0.73	1.72	1	4	1	0	100%	1
3EC7_EPE_E_401	100%	10%	0.031	0.993	1.1	3.18	1	11	1	0	100%	1
2BDU_EPE_B_402	100%	29%	0.033	0.993	0.87	1.95	1	5	0	0	100%	1
3R7A_EPE_B_301	99%	39%	0.053	0.987	0.79	1.56	1	4	1	0	100%	1
4WX4_EPE_A_302	99%	53%	0.064	0.994	0.99	0.82	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.